Envision Pharma Group has appointed Nick Jones as President, Envision Medical Communications (EMC), bringing extensive technology and life sciences expertise to one of the company’s core business units.

Jones, who will join Envision’s Executive Leadership Team and report directly to Tom Langan, CEO of Envision Pharma Group, will lead the EMC business, focusing on integrating Envision’s technology and AI capabilities across its medical communications portfolio.

Jones comes to Envision from ConcertAI, where he served as Senior Vice President and General Manager, Commercial Solutions, leading teams that delivered consulting services, AI-driven software‑as‑a‑service solutions, and data products supporting pharmaceutical commercialization.

Before that, he spent over a decade at IQVIA (formerly IMS), leading technology and consulting organizations across the US, Europe, and JAPAC, with a portfolio spanning real-world evidence, analytics, and integrated pharma solutions for global and mid-size clients.

Langan says, “Nick brings deep expertise, global market insight, and a shared ambition to build a world-class, tech-enabled pharma services organization. His broad experience across technology and consulting will benefit both Envision and our clients.”

Jones adds, “Envision has consistently stood out in the pharma services industry for its credibility and excellence in medcomms. I am excited to join the company, and EMC in particular, as we build a market-leading, tech-enabled portfolio to meet the evolving needs of our pharma clients.”

This appointment reflects Envision’s ongoing evolution as a solutions partner to the life sciences industry, with a growing emphasis on the responsible and practical application of AI to support scientific exchange, strategy, and communication across the product lifecycle.